Платежечки во время ремонта Myelin в Множестве склероза: друг или Фо?
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rivera Francisco J, Philp Amber R, Reyes Carolina R, Valenzuela-Krugmann Carlos, Silva Maria Elena
Аннотация
Оригинал публикации
Platelets During Myelin Repair in Multiple Sclerosis: Friend or Foe?
Multiple sclerosis (MS) is an autoimmune neuroinflammatory demyelinating disease of the central nervous system (CNS) that affects more than 2.5 million people worldwide. Remyelination represents a robust regenerative response to myelin damage; however, during the later stages of MS, this process largely fails. Upon demyelination, oligodendrocyte progenitor cells (OPCs) proliferate, migrate, and differentiate into mature remyelinating oligodendrocytes. Why does remyelination fail in MS? Platelets are small, oval, anucleate cells that circulate in the bloodstream and form a hemostatic plug to stop blood leakage upon endothelial damage. Platelet function is not restricted to hemostasis; they also display tissue-regenerative activities. Here, we review evidence suggesting that platelets act as modulators of OPC function during remyelination. Additionally, we describe platelet alterations associated with MS that may contribute to remyelination failure. Finally, we highlighted our previous study that addressed these issues. This study showed that in response to myelin damage, platelets transiently accumulate within the lesion. Interestingly, platelet depletion leads to a reduction in OPC differentiation, hindering remyelination. In vitro studies revealed that transient exposure to platelets boosts OPC differentiation, whereas sustained exposure to platelets suppresses this beneficial effect. Consistent with this observation, in an in vivo model of thrombocytosis (Calr+/-), we found a sustained increase in the number of blood-borne platelets recruited into the CNS (as observed in MS lesions), resulting in a significant decline in OPC differentiation during remyelination. These findings reveal a complex role of platelets in remyelination and provide new insights for understanding the MS pathology as well as for designing regenerative strategies for the treatment of this disease.